These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 1983321)

  • 1. Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists.
    Lundell L; Backman L; Ekström P; Enander LH; Fausa O; Lind T; Lönroth H; Sandmark S; Sandzén B; Unge P
    Aliment Pharmacol Ther; 1990 Apr; 4(2):145-55. PubMed ID: 1983321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lansoprazole versus ranitidine in the maintenance treatment of reflux oesophagitis.
    Gough AL; Long RG; Cooper BT; Fosters CS; Garrett AD; Langworthy CH
    Aliment Pharmacol Ther; 1996 Aug; 10(4):529-39. PubMed ID: 8853756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term treatment of refractory reflux esophagitis with different doses of omeprazole or ranitidine.
    Bianchi Porro G; Pace F; Peracchia A; Bonavina L; Vigneri S; Scialabba A; Franceschi M
    J Clin Gastroenterol; 1992 Oct; 15(3):192-8. PubMed ID: 1479161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.
    Lundell L; Backman L; Ekström P; Enander LK; Falkmer S; Fausa O; Grimelius L; Havu N; Lind T; Lönroth H
    Scand J Gastroenterol; 1991 Mar; 26(3):248-56. PubMed ID: 1853146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis.
    Klinkenberg-Knol EC; Jansen JM; Festen HP; Meuwissen SG; Lamers CB
    Lancet; 1987 Feb; 1(8529):349-51. PubMed ID: 2880161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of relapse of reflux oesophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.
    Lundell L
    Digestion; 1990; 47 Suppl 1():72-5. PubMed ID: 2093020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omeprazole is superior to ranitidine plus metoclopramide in the short-term treatment of erosive oesophagitis.
    Robinson M; Decktor DL; Maton PN; Sabesin S; Roufail W; Kogut D; Roberts W; McCullough A; Pardoll P; Saco L
    Aliment Pharmacol Ther; 1993 Feb; 7(1):67-73. PubMed ID: 8439639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of omeprazole and histamine H2-receptor antagonists in the treatment of elderly and young patients with reflux oesophagitis.
    James OF; Parry-Billings KS
    Age Ageing; 1994 Mar; 23(2):121-6. PubMed ID: 8023719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omeprazole or ranitidine in long-term treatment of reflux esophagitis. The Scandinavian Clinics for United Research Group.
    Hallerbäck B; Unge P; Carling L; Edwin B; Glise H; Havu N; Lyrenäs E; Lundberg K
    Gastroenterology; 1994 Nov; 107(5):1305-11. PubMed ID: 7926494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis. The Dutch Lansoprazole Study Group.
    Jansen JB; Van Oene JC
    Aliment Pharmacol Ther; 1999 Dec; 13(12):1611-20. PubMed ID: 10594396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study.
    van Zyl JH; de K Grundling H; van Rensburg CJ; Retief FJ; O'Keefe SJ; Theron I; Fischer R; Bethke T
    Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):197-202. PubMed ID: 10741935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study.
    Sandmark S; Carlsson R; Fausa O; Lundell L
    Scand J Gastroenterol; 1988 Jun; 23(5):625-32. PubMed ID: 3041558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of omeprazole with ranitidine in the treatment of reflux oesophagitis.
    Zeitoun P
    Scand J Gastroenterol Suppl; 1989; 166():83-7; discussion 94. PubMed ID: 2690335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine.
    Brunner GH; Lamberts R; Creutzfeldt W
    Digestion; 1990; 47 Suppl 1():64-8; discussion 76. PubMed ID: 2093018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omeprazole in patients with mild or moderate reflux esophagitis induces lower relapse rates than ranitidine during maintenance treatment.
    Annibale B; Franceschi M; Fusillo M; Beni M; Cesana B; Delle Fave G
    Hepatogastroenterology; 1998; 45(21):742-51. PubMed ID: 9684126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP; Schenk E; Tan G; Snel P; Nelis F
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of omeprazole versus ranitidine for symptomatic treatment of poorly responsive acid reflux disease-a prospective, controlled trial.
    Maton PN; Orlando R; Joelsson B
    Aliment Pharmacol Ther; 1999 Jun; 13(6):819-26. PubMed ID: 10383513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.
    McTavish D; Buckley MM; Heel RC
    Drugs; 1991 Jul; 42(1):138-70. PubMed ID: 1718683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.